GCP
FBT icon

Gill Capital Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Gill Capital Partners’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.9K Hold
145
– – 0.01% 309
2026
Q1 		$29.1K Buy
+145
New +$30K 0.01% 321

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Gill Capital Partners's FBT Position: Q2 2026 in Review

Gill Capital Partners held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q2 2026 at 145 shares worth $35.9K. The position accounts for 0.01% of the portfolio, ranked #309.

Gill Capital Partners first reported a position in FBT in Q1 2026 and has held it in 2 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Gill Capital Partners held 145 shares of First Trust NYSE Arca Biotechnology Index Fund worth $35.9K as of Q2 2026.
  • Gill Capital Partners left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q2 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Gill Capital Partners's portfolio in Q2 2026, its #309 holding.
  • Gill Capital Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2026 and has held it in 2 quarters since.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Gill Capital Partners's 13F filing for Q2 2026, filed 20 Aug 2026.